Compare VRDN & LASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRDN | LASR |
|---|---|---|
| Founded | 2006 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 2014 | 2018 |
| Metric | VRDN | LASR |
|---|---|---|
| Price | $30.42 | $67.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | $41.17 | ★ $50.56 |
| AVG Volume (30 Days) | 1.2M | ★ 1.9M |
| Earning Date | 05-25-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.99 |
| EPS | N/A | ★ N/A |
| Revenue | $5,706,000.00 | ★ $191,359,000.00 |
| Revenue This Year | $13.90 | $9.24 |
| Revenue Next Year | $284.55 | $13.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 38.09 |
| 52 Week Low | $9.90 | $6.20 |
| 52 Week High | $34.29 | $69.52 |
| Indicator | VRDN | LASR |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 66.45 |
| Support Level | $21.50 | $27.61 |
| Resistance Level | $33.71 | N/A |
| Average True Range (ATR) | 1.60 | 4.67 |
| MACD | 0.26 | 0.80 |
| Stochastic Oscillator | 92.69 | 87.48 |
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.